For research use only. Not for therapeutic Use.
cis-ACCP is an orally active antimetastatic matrix metalloproteinase-2 (MMP-2) selective inhibitor. cis-ACCP can inhibit MMP-2 and MMP-9 with IC50 values of 4 μM and 20 μM, respectively. cis-ACCP can be used for the research of a variety of chronic diseases[1].
cis-ACCP can inhibit MMP-2 and MMP-9 with IC50 values of 4 μM and 20 μM, respectively[1].
cis-ACCP (i.p.; 50, 250, 500 mg/kg; daily for two weeks) shows no toxic effects and reduces metastasis formation in mice[1].
cis-ACCP (oral, i.v.,i.p.; 50, 150 mg/kg) only has distribution in the extracellular fluid[1].
Pharmacokinetic Parameters of cis-ACCP in rats[1].
PK parameter
iv
PO
ip
AUC (min • µg/mL)
7637
79
2677
T1/2 (min)
18.8
126
108
Cmax(ng/mL)
306000
712
144000
CL (mL/min/kg)
6.9
–
–
Tmax(min)
–
17.4
0.5
Vss(mL/Kg)
186
–
–
F (%)
–
0.35
11.8
Fu (%)
83.9
2.2
48
Ttime over MIC (hr)
>4
>6
24
Catalog Number | I011668 |
CAS Number | 777075-44-2 |
Synonyms | [(1R,2S)-2-aminocyclohexyl]carbamoylphosphonic acid |
Molecular Formula | C7H15N2O4P |
Purity | ≥95% |
InChI | InChI=1S/C7H15N2O4P/c8-5-3-1-2-4-6(5)9-7(10)14(11,12)13/h5-6H,1-4,8H2,(H,9,10)(H2,11,12,13)/t5-,6+/m0/s1 |
InChIKey | XHCXISPZIHYKQD-NTSWFWBYSA-N |
SMILES | C1CCC(C(C1)N)NC(=O)P(=O)(O)O |
Reference | [1]. Hoffman, Amnon et al. Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor–synthesis and pharmacodynamic and pharmacokinetic analysis. Journal of medicinal chemistry vol. 51,5 (2008): 1406-14. |